drugset / Trial / NCT00472368
A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589
NaSingle-groupOpen-labelTreatment
Summary
This single center study will help determine the absorption, metabolism, and excretion of LBH589 and to assess the safety and efficacy of LBH589 in advanced cancer patients for whom no standard therapy exists.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panobinostat | Small molecule | 20 mg | Oral |
Indications
No indication recorded.